GSK plc GSK
NYSE GSK
$49.10 -0.40 (-0.82%)
As of: Nov 2, 2026 · 3:59 PM EST

Gsk (GSK) EBIT (2009 - 2026)

Updated

Gsk's EBIT came in at $2.86 billion for the quarter ended Sep 30, 2026, down 18.3% from $3.5 billion a year earlier but up 342.8% from the prior quarter.

Analysis

Gsk (GSK) EBIT (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Gsk reported EBIT of $17.15 billion, up 73.5% year-over-year; for the year ended Dec 31, 2025, it was $10.46 billion, up 103.5% from the prior year.

  • EBIT carries a five-year compound annual growth rate of 6.4% (years ended Dec 2020 to Dec 2025).
  • Going back by year, EBIT was $5.14 billion in the year ended Dec 31, 2024 (-38.7%), $8.39 billion in the year ended Dec 31, 2023 (+5.4%), $7.96 billion in the year ended Dec 31, 2022 (+32.8%) and $5.99 billion in the year ended Dec 31, 2021 (-21.9%).
  • The five-year range for quarterly EBIT is $245.57 million (the quarter ended Sep 30, 2024) to $10.55 billion (the quarter ended Dec 31, 2025).
  • Year-over-year, EBIT increased in four of the last six quarters, with growth averaging 3.3%.
  • The fastest year-over-year change in EBIT over five years came in the quarter ended Dec 31, 2022 (growth of 230.4%), and the weakest in the quarter ended Sep 30, 2024 (a decline of 90.1%).
  • Business Quant data shows GSK's EBIT at $645.35 million (quarter ended Jun 30, 2026), $3.09 billion (quarter ended Mar 31, 2026) and $10.55 billion (quarter ended Dec 31, 2025) in the three quarters before the quarter ended Sep 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,263.50 Bn 1,237.12 Bn 20.46 Bn 12.79 Bn
2 Johnson & Johnson 655.05 Bn 574.91 Bn 17.30 Bn 6.18 Bn
3 AbbVie 512.00 Bn 485.11 Bn 12.70 Bn 6.43 Bn
4 Merck 368.57 Bn 368.57 Bn - -
5 Novartis Ag 313.61 Bn 286.85 Bn - -
6 Astrazeneca 290.22 Bn 263.91 Bn 12.86 Bn 3.16 Bn
7 Amgen 252.64 Bn 208.04 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 212.62 Bn 212.62 Bn - -
9 Pfizer 175.96 Bn 122.60 Bn 10.94 Bn 4.27 Bn
10 Gsk 99.60 Bn 82.45 Bn 8.73 Bn 2.86 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 2.86 Bn
Jun 30, 2026 645.35 Mn
Mar 31, 2026 3.09 Bn
Dec 31, 2025 10.55 Bn
Sep 30, 2025 3.50 Bn
Jun 30, 2025 2.70 Bn
Mar 31, 2025 2.79 Bn
Dec 31, 2024 893.32 Mn
Sep 30, 2024 245.57 Mn
Jun 30, 2024 2.08 Bn
Mar 31, 2024 1.89 Bn
Dec 31, 2023 711.18 Mn
Sep 30, 2023 2.47 Bn
Jun 30, 2023 2.68 Bn
Mar 31, 2023 2.53 Bn
Dec 31, 2022 2.19 Bn
Sep 30, 2022 1.40 Bn
Jun 30, 2022 1.36 Bn
Mar 31, 2022 3.08 Bn
Dec 31, 2021 663.22 Mn
API Access

Gsk EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=GSK&period=max&api_key=YOUR_API_KEY